The Politics of Biosimilars: Understanding Stakeholder Influence Over Complex Policy Problems
The health care industry’s involvement with biosimilar policies suggests that building coalitions and reducing opposition are critical factors for interest group success. As government decision-makers wrestle with how to handle a perplexing category of prescription drugs, companies and patient group...
| Main Author: | |
|---|---|
| Format: | Others |
| Published: |
Scholarship @ Claremont
2018
|
| Subjects: | |
| Online Access: | http://scholarship.claremont.edu/cmc_theses/1815 http://scholarship.claremont.edu/cgi/viewcontent.cgi?article=2800&context=cmc_theses |